Unproven drug of efficacy equivalency to reject insurance reimbursement.

Published: 2001-05-10 07:00:00

Updated: 2001-05-10 07:00:00

The MOHW announced to legislate a provision on May 7 covering that 5,735 products manufactured by 186 companies of no drug efficacy equivalent tests being completed would not allow the medical insurance reimbursement unless at least a comparative dissolution test being proven until coming Oct aft...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK